Adalta Capital Management LLC Amarin Corp Plcuk Transaction History

Adalta Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$4.26 - $6.5 $175,788 - $268,222	-41,265 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$4.04 - $5.31 $375,922 - $494,095	-93,050 Reduced 69.28%	41,265 $202,000
Q3 2020 Nov 17, 2020	SELL	$3.64 - $7.76 $99,918 - $213,012	-27,450 Reduced 16.97%	134,315 $566,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $310,461 - $536,487	-64,950 Reduced 28.65%	161,765 $1.12 Million
Q1 2020 May 18, 2020	BUY	$4.0 - $21.53 $38,400 - $206,688	9,600 Added 4.42%	226,715 $906,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $277,057 - $479,385	-19,875 Reduced 8.39%	217,115 $4.66 Million
Q3 2019 Nov 15, 2019	BUY	$13.89 - $23.16 $480,107 - $800,525	34,565 Added 17.08%	236,990 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $3.13 Million - $3.94 Million	192,075 Added 1855.8%	202,425 $3.93 Million
Q1 2019 May 16, 2019	BUY	$12.61 - $22.33 $130,513 - $231,115	10,350 New	10,350 $215,000

187

77.1M

247K

121K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Adalta Capital Management LLC with notifications on news.